Haleblian, G. E., Sur, R. L., Pierre, S. A., Robinson, M. R., Albala, D. M., & Preminger, G. M. (2007). 1444: Efficacy of Intravesical Ropivacaine Injection on Urinary Symptoms following Ureteral Stenting: A Randomized, Controlled Study. In Journal of Urology (Vol. 177, pp. 477–477). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/s0022-5347(18)31645-8

Haleblian, George E., Roger L. Sur, Sean A. Pierre, Mamie R. Robinson, David M. Albala, and Glenn M. Preminger. “1444: Efficacy of Intravesical Ropivacaine Injection on Urinary Symptoms following Ureteral Stenting: A Randomized, Controlled Study.” In Journal of Urology, 177:477–477. Ovid Technologies (Wolters Kluwer Health), 2007. https://doi.org/10.1016/s0022-5347(18)31645-8.

Haleblian GE, Sur RL, Pierre SA, Robinson MR, Albala DM, Preminger GM. 1444: Efficacy of Intravesical Ropivacaine Injection on Urinary Symptoms following Ureteral Stenting: A Randomized, Controlled Study. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 477–477.

Haleblian, George E., et al. “1444: Efficacy of Intravesical Ropivacaine Injection on Urinary Symptoms following Ureteral Stenting: A Randomized, Controlled Study.” Journal of Urology, vol. 177, no. 4S, Ovid Technologies (Wolters Kluwer Health), 2007, pp. 477–477. Crossref, doi:10.1016/s0022-5347(18)31645-8.

Haleblian GE, Sur RL, Pierre SA, Robinson MR, Albala DM, Preminger GM. 1444: Efficacy of Intravesical Ropivacaine Injection on Urinary Symptoms following Ureteral Stenting: A Randomized, Controlled Study. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 477–477.